Molecular docking and identification of G-protein-coupled receptor 120 (GPR120) agonists as SARS COVID-19 MPro inhibitors

COVID-19 has become a pandemic, and any new drug for treating the disease could save millions of lives. Several drugs already in use for other diseases and medical conditions are repurposed for treating COVID-19 in an attempt to find treatment for the disease without spending research time on ADME T...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohan, Sellappan, Dharani, Jayagopal, Natarajan, Ramanathan, Nagarajan, Arumugam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289937/
https://www.ncbi.nlm.nih.gov/pubmed/35849279
http://dx.doi.org/10.1186/s43141-022-00375-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289937/
https://www.ncbi.nlm.nih.gov/pubmed/35849279
http://dx.doi.org/10.1186/s43141-022-00375-8

Ejemplares similares